VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $412,000 | -29.2% | 17,731 | -51.4% | 0.01% | +25.0% |
| Q1 2018 | $582,000 | +50.0% | 36,512 | +95.7% | 0.00% | -20.0% |
| Q4 2017 | $388,000 | +42.6% | 18,656 | -1.8% | 0.01% | +25.0% |
| Q3 2017 | $272,000 | -17.3% | 19,006 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $329,000 | +52.3% | 19,006 | -2.8% | 0.01% | +66.7% |
| Q1 2017 | $216,000 | -15.3% | 19,556 | +678.5% | 0.00% | -25.0% |
| Q4 2015 | $255,000 | -60.0% | 2,512 | -29.6% | 0.00% | -63.6% |
| Q3 2015 | $637,000 | -8.2% | 3,567 | +14.1% | 0.01% | 0.0% |
| Q2 2015 | $694,000 | +11.6% | 3,125 | -0.2% | 0.01% | +10.0% |
| Q1 2015 | $622,000 | -7.7% | 3,131 | -33.6% | 0.01% | -9.1% |
| Q4 2014 | $674,000 | +9.2% | 4,713 | +0.3% | 0.01% | +10.0% |
| Q3 2014 | $617,000 | +5.3% | 4,700 | +1.1% | 0.01% | 0.0% |
| Q2 2014 | $586,000 | -0.8% | 4,649 | +3.7% | 0.01% | 0.0% |
| Q1 2014 | $591,000 | -12.2% | 4,482 | -21.8% | 0.01% | -16.7% |
| Q4 2013 | $673,000 | +12.5% | 5,732 | 0.0% | 0.01% | +9.1% |
| Q3 2013 | $598,000 | +21.5% | 5,732 | +0.3% | 0.01% | +22.2% |
| Q2 2013 | $492,000 | +14.7% | 5,717 | 0.0% | 0.01% | +12.5% |
| Q1 2013 | $429,000 | – | 5,717 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |